Real-time enrollment status for this androgen axis suppression clinical trial
Current Status
Recruiting
Checked: July 23, 2026 at 2:31 AM UTC
| NCT Number | NCT06274047 |
| Recruiting Status | Recruiting |
| Condition | Androgen Axis Suppression |
| Phase | PHASE3 |
| Target Enrollment | 120 participants |
| Active Locations | 6 sites in the US |
| Sponsor | M.D. Anderson Cancer Center |
| Last Updated on CT.gov | July 22, 2026 (Yesterday) |
As of July 23, 2026: Clinical trial NCT06274047 is currently recruiting participants. This phase3 study for androgen axis suppression is actively seeking new participants at 6 locations across the United States. The study is sponsored by M.D. Anderson Cancer Center. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06274047 is actively recruiting participants as of July 23, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 6 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06274047 was last updated Yesterday (July 22, 2026). HelloStudys verifies this status automatically.